- Home
- CLNN vs CVM Comparison
CLNN vs CVM Comparison
Compare CLNN & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- CVM
- Stock Information
- Founded
- CLNN 2012
- CVM 1983
- Country
- CLNN United States
- CVM United States
- Employees
- CLNN N/A
- CVM N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLNN Health Care
- CVM Health Care
- Exchange
- CLNN Nasdaq
- CVM Nasdaq
- Market Cap
- CLNN 43.0M
- CVM 35.7M
- IPO Year
- CLNN N/A
- CVM 1987
- Fundamental
- Price
- CLNN $4.00
- CVM $0.61
- Analyst Decision
- CLNN Strong Buy
- CVM
- Analyst Count
- CLNN 4
- CVM 0
- Target Price
- CLNN $59.25
- CVM N/A
- AVG Volume (30 Days)
- CLNN 56.3K
- CVM 437.3K
- Earning Date
- CLNN 11-13-2024
- CVM 12-19-2024
- Dividend Yield
- CLNN N/A
- CVM N/A
- EPS Growth
- CLNN N/A
- CVM N/A
- EPS
- CLNN N/A
- CVM N/A
- Revenue
- CLNN $421,000.00
- CVM N/A
- Revenue This Year
- CLNN N/A
- CVM N/A
- Revenue Next Year
- CLNN $1,058.37
- CVM $3,412.81
- P/E Ratio
- CLNN N/A
- CVM N/A
- Revenue Growth
- CLNN N/A
- CVM N/A
- 52 Week Low
- CLNN $3.82
- CVM $0.54
- 52 Week High
- CLNN $12.00
- CVM $3.23
- Technical
- Relative Strength Index (RSI)
- CLNN 32.52
- CVM 30.20
- Support Level
- CLNN $3.88
- CVM $0.55
- Resistance Level
- CLNN $4.78
- CVM $0.92
- Average True Range (ATR)
- CLNN 0.50
- CVM 0.06
- MACD
- CLNN -0.18
- CVM -0.00
- Stochastic Oscillator
- CLNN 9.48
- CVM 22.54
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.